Journal Guide

The Lancet Haematology launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence that advocate a change in, or illuminate, haematological clinical practice.

The Lancet Haematology builds onThe Lancet journals' reputation for publishing high-impact research and covers the breadth of clinical haematology which includes, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine.

Following in The Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research.

Visit http://www.thelancet.com/haematology for more information.

The Lancet Healthy Longevity is an open-access, multi-disciplinary journal that publishes clinically-focussed longevity and healthy ageing research and review. The broad research remit aims to encompass early-stage clinical research into the mechanisms of ageing through to epidemiological and societal research on changing populations, including clinical trials in all disciplines focussed on older people, gerontological science, and age-specific clinical guidelines. We will also publish clinical and policy reviews which aim to shape and contextualise the debate on this fast-growing discipline. The Lancet Healthy Longevity will continue in the Lancet family tradition of being a strong advocate for the rights of all people to healthy, fulfilling lives, irrespective of age, and prioritises reports of original research that are likely to change clinical practice or thinking.

The Lancet Infectious Diseases is recognized for providing a global, authoritative, and independent forum for the highest quality infectious diseases research and opinion, covering the research and treatment of diseases and conditions such as HIV/AIDS, healthcare association infections, antibiotic resistance, malaria, tuberculosis, emerging infections, and public health. The Lancet Infectious Diseases publishes original research, reviews, personal views, commentaries, and news across the global field of infectious diseases. The journal is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research is fast-tracked to publication within 8 weeks on average of submission and published first online on TheLancet.com before the print issue.

The Lancet Microbe publishes original research, review, and personal views on clinically relevant microbes at all scales—from the nature of the microbe (eg, antimicrobial resistance genes/plasmids, virulence factors) to the microbiome, to pathology (including immunology) to population level effects (eg, outbreaks, epidemiology). Furthermore, it includes early phase clinical trials and other interventional studies where the outcomes are focused on the pathogen. Lancet Microbe provides a destination for the best microbiology-focused clinical research and review. All submissions are handled in the rigorous manner expected of any journal within the Lancet family. Also in keeping with the Lancet ethos, Lancet Microbe is a strong advocate for and collaborator with the microbial research community.

The Lancet Neurology is recognized for providing a global, authoritative, and independent forum for the highest quality clinical neurology research, reviews, and news covering all areas of global clinical neurology with a particular focus in the research and treatment of stroke, multiple sclerosis, movement disorders, epilepsy, dementia, and headache.The Lancet Neurology publishes original research, reviews, personal views, commentaries, and news across the global field of clinical neurology. The journal is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research is fast-tracked to publication within 8 weeks of submission and published first online on TheLancet.com before the print issue.With an impact factor of 23.917*, the journal ranks highest among the world's leading clinical neurology journals and has maintained this leading position in the Journal Citation Reports® since 2004.Visit www.TheLancet.com to find out more about The Lancet Neurology.* 2012 Journal Citation Reports, Thomson Reuters© 2013.

The Lancet Oncology is recognized for providing a global, authoritative, and independent forum for the highest quality clinical oncology research and opinion. With an impact factor of 25.12, the journal ranks third out of 194 oncology journals worldwide, is the leading clinical research journal in oncology, and is in the top 0.5% of all scientific journals, of any discipline, globally (2012 Journal Citation Reports®, © Thomson Reuters 2013).The Lancet Oncology publishes original research, reviews, personal views, commentaries, and news across the global field of oncology. The journal is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research is fast-tracked to publication within 8 weeks of submission and published first online on TheLancet.com before the print issue. Articles published in The Lancet Oncology regularly receive coverage in the mainstream print, online, and broadcast media.Visit www.TheLancet.com to find out more about The Lancet Oncology.

The Lancet Planetary Health is a monthly, open access, online-only title in The Lancet's growing family of specialty journals. Building on the foundation of The Rockefeller Foundation-Lancet Commission on planetary health, the journal is committed to publishing high-quality original Research Articles, Editorials, Comments, and Correspondence that contribute to defining and advancing planetary health worldwide.

Planetary health has been defined as the health of the human civilisation and the state of the natural systems on which it depends.

To explain this idea in simple terms we need to think of humanity as one of the key driving forces of global environmental change. We live on a planet that is shaped by the activity of human beings. We have benefited from the exploitation of the natural resources of the environment, and this has allowed us to develop, flourish, and to improve our health. But, we have now gone beyond a sustainable limit. The planet we live in is in grave danger. Species are under pressure. The environmental changes to the climate, the water, the land, and ecosystems are challenging life on the Earth with serious implications for our health and wellbeing. The way we think about the planet needs to be revised and with it the approach we take to interact with it.

It is against this backdrop that we welcome The Lancet Planetary Health. In keeping with our other journals, The Lancet Planetary Health will offer rapid publication of research online within 8-12 weeks from submission. We invite all original research submissions that have the potential to change or challenge the interplay between the environment and human health. We take a broad and inclusive approach to planetary health, and we especially wish to emphasise our interest in interdisciplinary and transdisciplinary research.

Submissions are subjected to The Lancet's usual rigorous standards of external and statistical peer review, and are edited by experienced copy editors to the highest standards. All original research remains the property of the author, and reuse by others is permitted under either CC BY or CC BY-NC-ND Creative Commons licences, depending on authors' preferences or funding bodies' mandates.

For full details of how to submit your paper, including methods of funding, please visit http://ees.elsevier.com/tlplanetaryhealth. Read more about the scope and aims of this exciting new journal at www.thelancet.com/planetary-health.

The Lancet Psychiatry launched in print and online in June 2014, following in the footsteps of other Lancet specialty journals such as The Lancet Oncology and The Lancet Neurology. The journal offers the same fast track experience offered by its sister journals for all authors of research papers that are selected for peer review, where articles can be published online within 8 weeks of submission.

The journal publishes a range of article types in psychiatry, including Original Research, Reviews, Personal Views, Comments, and News articles. Topics include psychopharmacology, psychotherapy and psychosocial approaches to all psychiatric disorders, across the life course. The journal covers innovative treatments and the biological research underpinning such developments, novel methods of service delivery, and new ways of thinking about mental illness promoted by social psychiatry. The journal will also advocate strongly for the rights of people with mental health disorders, and welcome the voices of service users.

Visit http://www.thelancet.com/psychiatrywww.thelancet.com/psychiatry for more information.

The Lancet Public Health is a new online-only, open access title in The Lancet’s growing family of specialty journals. Building on the foundation of The Lancet as a champion of public health research, this monthly journal is committed to publishing high-quality original Research, Articles, Editorials, Comments and Correspondence that contribute to advancing public health practice and policy making worldwide.

The Lancet publishes medical news, original research, and reviews on all aspects of clinical medicine and global health. The journal is committed to applying scientific knowledge to improve health and advance human progress, and this is as true today as it was when the first issue was published on October 5, 1823.

The Lancet Respiratory Medicine launched in March 2013 and is the fourth Lancet specialty journal following in the footsteps of The Lancet Oncology, The Lancet Neurology, and The Lancet Infectious Diseases. The journal offers the same unique fast track experience offered by its sister journals for all authors of research papers that are selected for peer review, where articles can be published online within 8 weeks of submission.The journal publishes a range of article types in respiratory medicine and critical care. These include Original Research, Reviews, Personal Views, Comments, and News articles. Topics include but are not limited to asthma, COPD, tobacco control, critical care, lung cancer, cystic fibrosis, pneumonia, sarcoidosis, mesothelioma, sleep medicine, thoracic and reconstructive surgery, tuberculosis, palliative medicine, and respiratory infections.Visit www.thelancet.com/respiratory for more information.

Disciplines such as political science, organizational psychology and sociology are becoming so specialized that, for scholars and lay persons alike, the study of leadership is now highly fractionated. Studies of US presidents in political science seldom make reference to the psychological literature of chief executive officers. Studies of school principals appear without attention to the impact of cultural dynamics seen in cultural anthropology.Management and administrative staffs responsible for supervisory and executive development need to scan 20 to 30 journals across many disciplines to keep current in the study of leadership.This journal brings together a focus on leadership for scholars, consultants, practicing managers, executives and administrators, as well as those numerous university faculty members across the world who teach leadership as a college course. It provides timely publication of leadership research and applications and has a global reach. It also focuses on yearly reviews of a broad range of leadership topics on a rotating basis and emphasizes cutting edge areas through special issues.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The North-American Journal of Economics and Finance publishes high quality original manuscripts in financial economics. Areas of interest include, but not limited to financial intermediation and capital markets, law and finance, asset pricing, global and regional integration of financial markets, capital and security markets, corporate governance, information and security markets, behavioral finance, corporate financial policy and financial econometrics. The journal makes extra efforts toward maintaining a balance between theoretical and empirical work, and aims to provide prompt and constructive reviews to author(s). Empirical analysis should be capable of replication. Authors of accepted papers will be encouraged to supply data and computer programs.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The Ocular Surface, a quarterly, a peer-reviewed journal, is an authoritative resource that integrates and interprets major findings in diverse fields related to the ocular surface, including ophthalmology, optometry, genetics, molecular biology, pharmacology, immunology, infectious disease, and epidemiology. Its critical review articles cover the most current knowledge on medical and surgical management of ocular surface pathology, new understandings of ocular surface physiology, the meaning of recent discoveries on how the ocular surface responds to injury and disease, and updates on drug and device development. The journal also publishes select original research reports and articles describing cutting-edge techniques and technology in the field.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The Quarterly Review of Economics and Finance (QREF) attracts and publishes high quality manuscripts that cover topics in the areas of economics, financial economics and finance. The subject matter may be theoretical, empirical or policy related. Emphasis is placed on quality, originality, clear arguments, persuasive evidence, intelligent analysis and clear writing. At least one Special Issue is published per year. These issues have guest editors, are devoted to a single theme and the papers have well known authors. In addition we pride ourselves in being able to provide three to four article "Focus" sections in most of our issues. These "Focus" sections have a common theme, may or may not have a guest editor, and often contain papers that were presented in a session at a regional, national or international meeting. These can be published in a very timely manner. Finally, QREF is the journal of the Midwest Economic Association. At least two members are chosen by this organization to serve on the editorial board. The editors of QREF place special efforts into working with young authors.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com